134 related articles for article (PubMed ID: 2439266)
1. The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions.
Silverman JF; Nance K; Phillips B; Norris HT
Diagn Cytopathol; 1987 Jun; 3(2):134-40. PubMed ID: 2439266
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies in the cytodiagnosis of serous effusions.
al-Nafussi A; Carder PJ
Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
[TBL] [Abstract][Full Text] [Related]
4. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
5. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
6. Value of immunocytochemistry in the study of malignant effusions.
Mason MR; Bedrossian CW; Fahey CA
Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
[TBL] [Abstract][Full Text] [Related]
7. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.
Sehested M; Ralfkjaer E; Rasmussen J
Acta Cytol; 1983; 27(2):124-7. PubMed ID: 6340401
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
[TBL] [Abstract][Full Text] [Related]
9. Distinction between cells in serous effusions using a panel of antibodies.
Lauritzen AF
Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):299-304. PubMed ID: 2441518
[TBL] [Abstract][Full Text] [Related]
10. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy.
Gandhi AK; Nayar M; Bihari N; Chandra M
Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis.
Esteban JM; Yokota S; Husain S; Battifora H
Am J Clin Pathol; 1990 Dec; 94(6):698-705. PubMed ID: 1700877
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical panel for the identification of malignant cells in serous effusions.
Nance KV; Silverman JF
Am J Clin Pathol; 1991 Jun; 95(6):867-74. PubMed ID: 1710419
[TBL] [Abstract][Full Text] [Related]
14. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
Orell SR; Dowling KD
Acta Cytol; 1983; 27(6):625-9. PubMed ID: 6196931
[TBL] [Abstract][Full Text] [Related]
15. Role of immunoperoxidase staining in serous effusions.
Sarker AB; Hoshida Y; Nose S
Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
[TBL] [Abstract][Full Text] [Related]
16. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
[TBL] [Abstract][Full Text] [Related]
19. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.
Cibas ES; Corson JM; Pinkus GS
Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
